Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5A replication complex inhibitor
CAS Number: 286930-03-8
6R)-2-{[(2R
InChiKey: KOQIAZNBAWFSQM-UHFFFAOYSA-N
Sandrock JE
Eprodisate Sodium - CAS# 36589-58-9 Catalog No.:M11419-10 Impact of a baseline polymorphismEprodisate, also known as 3 PDS; NC 503; 3PDS, is an orally available disodium salt form of eprodisate, a negatively charged sulfonated inhibitor of fibrillogenesis, that can be used in the treatment of amyloid A (AA) amyloidosis. Upon administration, eprodisate competitively binds to the glycosaminoglycan binding sites on serum amyloid A (SAA), which inhibits the formation of the glycosaminoglycan amyloid fibril aggregate. This prevents the formation
US$ 188.90
US$ 188.90
US$ 262.76
US$ 173.25
US$ 190.05
US$ 231.00
US$ 492.74
US$ 653.40
US$ 264.00
US$ 144.00
US$ 147.58
US$ 144.00
US$ 150.95
US$ 301.43